scholarly journals Computer-Assisted In Sensu Exposure for Posttraumatic Stress Disorder: Development and Evaluation

2016 ◽  
Vol 3 (2) ◽  
pp. e27 ◽  
Author(s):  
Nora Görg ◽  
Kathlen Priebe ◽  
Tilman Deuschel ◽  
Martin Schüller ◽  
Friederike Schriner ◽  
...  
Keyword(s):  
Posttraumatic Stress Disorder ◽  
Posttraumatic Stress ◽  
Dialectical Behavior Therapy ◽  
Stress Disorder ◽  
World Health ◽  
Computer Assisted ◽  
Ptsd Treatment ◽  
Dissociative States ◽  
Health Organization ◽  
Clinical Trials Registry

Background Dissociative states during psychotherapy sessions reduce the benefit of exposure-based therapy for posttraumatic stress disorder (PTSD). Thus, in evidence-based therapeutic programs such as dialectical behavior therapy for PTSD (DBT-PTSD), therapists apply specific antidissociative skills to reduce dissociative features during in sensu exposure. Objective This study sought to examine the acceptance and feasibility of the MORPHEUS program. Methods Patients who underwent 12 weeks of residential DBT-PTSD treatment used MORPHEUS during exposure exercises in self-management. After the treatment, they filled out evaluation questionnaires. Results In sum, 26 patients receiving a 12-week standard DBT-PTSD program participated in this study; 2 participants could not be analyzed because of missing data. All the patients used MORPHEUS as often as it was required according to the DBT-PTSD treatment (2 to 5 times a week). The overall acceptance and feasibility as rated by the patients was high: for example, patients found the skills useful to block dissociation (mean 4.24 on a scale from 0 to 5, SD 0.24) and stated that they would use the program again (mean 4.72 on a scale from 0 to 5, SD 0.11). Furthermore, patients indicated that they would recommend MORPHEUS to a friend (mean 4.44 on a scale from 0 to 5, SD 0.12). In 82% (32/39) of the cases, the use of antidissociative skills was related to a decrease in dissociation. In 18% (5/39), dissociation remained unchanged or increased. Conclusions The evaluative data suggest high acceptability and feasibility of MORPHEUS. Further studies should evaluate the effectiveness of the skills applied during the program. Trial Registration World Health Organization International Clinical Trials Registry Platform: DRKS00006226; http://apps.who.int/trialsearch/Trial2.aspx?TrialID= DRKS00006226 (Archived by WebCite at http://www.webcitation.org/ 6hxuFbIUr)

scholarly journals Using the World Health Organization Disability Assessment Schedule 2.0 to assess disability in veterans with posttraumatic stress disorder

PLoS ONE ◽  
2019 ◽  
Vol 14 (8) ◽  
pp. e0220806
Author(s):  
Michelle J. Bovin ◽  
Eric C. Meyer ◽  
Nathan A. Kimbrel ◽  
Sarah E. Kleiman ◽  
Jonathan D. Green ◽  
...  
Keyword(s):  
Posttraumatic Stress Disorder ◽  
World Health Organization ◽  
Posttraumatic Stress ◽  
Stress Disorder ◽  
World Health ◽  
Disability Assessment ◽  
The World ◽  
Health Organization

scholarly journals Subthreshold Posttraumatic Stress Disorder in the World Health Organization World Mental Health Surveys

2015 ◽  
Vol 77 (4) ◽  
pp. 375-384 ◽  
Author(s):  
Katie A. McLaughlin ◽  
Karestan C. Koenen ◽  
Matthew J. Friedman ◽  
Ayelet Meron Ruscio ◽  
Elie G. Karam ◽  
...  
Keyword(s):  
Mental Health ◽  
Posttraumatic Stress Disorder ◽  
World Health Organization ◽  
Posttraumatic Stress ◽  
Health Surveys ◽  
Stress Disorder ◽  
World Health ◽  
World Mental Health ◽  
The World ◽  
Health Organization

Complex Posttraumatic Stress Disorder and Rehabilitation Counseling

2021 ◽  
Vol 35 (3) ◽  
pp. 185-200
Author(s):  
Lynn C. Koch ◽  
Stephanie L. Lusk ◽  
Andrea Hampton Hall
Keyword(s):  
Posttraumatic Stress Disorder ◽  
Posttraumatic Stress ◽  
Stress Disorder ◽  
Psychiatric Disabilities ◽  
World Health ◽  
Complex Posttraumatic Stress Disorder ◽  
Affect Dysregulation ◽  
Successful Recovery ◽  
Health Organization ◽  
Disturbed Relationships

PurposeComplex posttraumatic stress disorder (CPTSD) is a multifaceted disorder, and the specific diagnostic criteria developed by the World Health Organization (WHO), which highlight symptoms of CPTSD (i.e., affect dysregulation, negative self-concept, disturbed relationships), that occur along with PTSD symptoms speak to this. Understanding the disorder itself and its ramifications is essential as our society is exposed to seemingly more and more traumatic and long-lasting events, all of which may lead to an increase in the number of overall cases. CPTSD is characterized by changes in three primary areas of the brain – hippocampus, amygdala, and medial prefrontal cortex (mPFC)– which are usually smaller in individuals with CPTSD, and there are certain subsets of individuals who have an increased likelihood of developing this disorder (e.g., individuals with physical and psychiatric disabilities, children exposed to long-term trauma).MethodThe authors conducted a scoping literature review on CPTSD, treatment approaches for individuals with CPTSD, and rehabilitation implications.ResultsTreatment for CPTSD is generally more extensive than treatment for PTSD and should be made available for those in need. There is a dearth of research on this topic in the rehabilitation literature; however, disability research has consistently shown that employment plays a huge role in successful recovery among individuals with psychiatric disabilities, which includes CPTSD.ConclusionIn order to ensure client success, rehabilitation counselors, educators, and researchers must understand the complexities associated with CPTSD and then how to best go about incorporating this information into individual plans for employment and our classrooms as well as making research in this area a priority for the field.

Embitterment in war veterans with posttraumatic stress disorder (PTSD)

2017 ◽  
Vol 41 (S1) ◽  
pp. S359-S360 ◽  
Author(s):  
D. Sabic ◽  
A. Sabic
Keyword(s):  
Posttraumatic Stress Disorder ◽  
Posttraumatic Stress ◽  
Health Center ◽  
Rating Scale ◽  
Stress Disorder ◽  
World Health ◽  
Control Group ◽  
War Veterans ◽  
Significant Difference ◽  
And Control

The aim of this study was to analyse frequency of embitterment in war veterans with Posttraumatic stress disorder (PTSD) as well as the potential impact of embitterment on the development of chronic PTSD.Patients and methodsIt was analyzed 174 subjects (from Health Center Zivinice/mental health center) through a survey conducted in the period from March 2015 to June 2016, of which 87 war veterans with PTSD and control subjects 87 war veterans without PTSD. The primary outcome measure was the post-traumatic embitterment disorder self-rating scale (PTED Scale) who contains 19 items designed to assess features of embitterment reactions to negative life events. Secondary efficacy measures included the clinician-administered PTSD scale–V (CAPS), the PTSD checklist (PCL), the combat exposure scale (CES), the Hamilton depression rating scale (HAM-D), the Hamilton anxiety rating scale (HAM-A) and the World health organization quality of life scale (WHOQOL-Bref). All subjects were male. The average age of patients in the group war veterans with PTSD was 52.78 ± 5.99. In the control group, average age was 51.42 ± 5.98. Statistical data were analyzed in SPSS statistical program.ResultsComparing the results, t-tests revealed significant difference between group veterans with PTSD and control group (t = −21,21, P < 0.0001). War veterans group with PTSD (X = 51.41, SD = 8,91), control group (X = 14.39, SD = 13.61).ConclusionEmbitterment is frequent in war veterans with PTSD.Disclosure of interestThe authors have not supplied their declaration of competing interest.

scholarly journals Differential Effects of Comorbid Psychiatric Disorders on Treatment Outcome in Posttraumatic Stress Disorder from Childhood Trauma

2021 ◽  
Vol 10 (16) ◽  
pp. 3708
Author(s):  
Nele Assmann ◽  
Eva Fassbinder ◽  
Anja Schaich ◽  
Christopher W. Lee ◽  
Katrina Boterhoven de Haan ◽  
...  
Keyword(s):  
Posttraumatic Stress Disorder ◽  
Treatment Outcome ◽  
Posttraumatic Stress ◽  
Childhood Trauma ◽  
Stress Disorder ◽  
Secondary Outcome ◽  
Ptsd Symptoms ◽  
Moderator Effect ◽  
Ptsd Treatment ◽  
The Impact

Patients with posttraumatic stress disorder (PTSD) frequently have comorbid diagnoses such as major depressive disorder (MDD) and anxiety disorders (AD). Studies into the impact of these comorbidities on the outcome of PTSD treatment have yielded mixed results. The different treatments investigated in these studies might explain the varied outcome. The purpose of this study was to examine the impact of these comorbidities on the outcome of two specific PTSD treatments. MDD and AD were analyzed as predictors and moderators in a trial comparing 12 sessions of either eye movement desensitization and reprocessing (EMDR) or imagery rescripting (IR) in 155 adult patients with PTSD from childhood trauma. The primary outcome was reduction of PTSD symptoms (clinician-administered PTSD Scale for DSM-5, CAPS-5) assessed at eight-week follow-up and a secondary outcome was self-report PTSD symptoms (Impact of Event Scale, IES-R). MDD was not a predictor of treatment outcome but did have a significant moderator effect. Patients with MDD showed a better outcome if they were treated with IR, whereas patients without MDD improved more in the EMDR condition. No impact of AD emerged. It seems essential to consider comorbid MDD when planning PTSD treatment to improve treatment outcomes. More research is needed to replicate our findings and focus on different kinds of PTSD treatments and other comorbidities.

Examining posttraumatic stress disorder as a predictor of treatment response to dialectical behavior therapy

2020 ◽  
Vol 76 (9) ◽  
pp. 1563-1574
Author(s):  
Kim L. Gratz ◽  
Christopher R. Berghoff ◽  
Julia R. Richmond ◽  
Ariana G. Vidaña ◽  
Katherine L. Dixon‐Gordon
Keyword(s):  
Posttraumatic Stress Disorder ◽  
Posttraumatic Stress ◽  
Treatment Response ◽  
Behavior Therapy ◽  
Dialectical Behavior Therapy ◽  
Stress Disorder

scholarly journals Treating posttraumatic stress disorder in substance use disorder patients with co-occurring posttraumatic stress disorder: study protocol for a randomized controlled trial to compare the effectiveness of different types and timings of treatment

2021 ◽  
Vol 21 (1) ◽  
Author(s):  
Sera A. Lortye ◽  
Joanne P. Will ◽  
Loes A. Marquenie ◽  
Anna E. Goudriaan ◽  
Arnoud Arntz ◽  
...  
Keyword(s):  
Posttraumatic Stress Disorder ◽  
Randomized Controlled Trial ◽  
Substance Use ◽  
Posttraumatic Stress ◽  
Substance Use Disorder ◽  
Stress Disorder ◽  
Controlled Trial ◽  
Ptsd Treatment ◽  
Randomized Controlled ◽  
Co Morbidity

Abstract Background Posttraumatic stress disorder (PTSD) and substance use disorder (SUD) have high comorbidity. Although prior research indicated that PTSD can effectively be treated with Prolonged Exposure (PE) in these patients, reported effects are small and treatment dropout rates high. Eye Movement Desensitization and Reprocessing (EMDR) and Imagery Rescripting (ImRs) are other promising treatment options for PTSD, that have not yet been examined in this patient group. Furthermore, it is unclear whether PTSD treatment is most effective when offered simultaneous to or after SUD treatment. Methods In this article, the Treatment Of PTSD and Addiction (TOPA) study is described: a Dutch randomized controlled trial (RCT) that studies the effectiveness of PTSD treatment as an add-on to regular SUD treatment in patients with SUD and co-occurring PTSD. Effects of PE, EMDR, ImRs, and a 3-month SUD treatment only condition will be compared, as well as simultaneous SUD/PTSD treatment to sequential SUD/PTSD treatment. The primary outcome measure is PTSD symptoms. Secondary outcomes are: treatment completion, psychological distress, substance use, interpersonal problems, emotion dysregulation, and trauma-related emotions guilt, shame, and anger. Discussion This study is the first to compare effects of PE, EMDR, and ImRs in one study and to compare simultaneous SUD/PTSD treatment to sequential SUD/PTSD treatment as well. This RCT will provide more knowledge about the effectiveness of different treatment strategies for PTSD in patients with co-occurring SUD and will ultimately improve treatment outcomes for patients with this common co-morbidity worldwide. Trial registration Netherlands Trial Register (NTR), Identifier: NL7885. Registered 22 July 2019.

Sign in / Sign up

Export Citation Format

Share Document